Danish Organisation Strategy
for The Global Fund to Fight AIDS, Tuberculosis and Malaria
Introduction
:
The Global Fund (GF) was established in 2001 with the aim of
gathering international support for the fight against AIDS,
tuberculosis (TB) and malaria, and working with partners to
support the most effective prevention and treatment
File No.
Responsible Unit
Mill.
Commitment
Projected ann. Disb.
Duration of strategy
Finance Act code.
Desk officer
Financial officer
82.C.1-4 / 2015-8838
FN-Genève
2017
2018
2019
Total (until 2019*)
Key results
:
GF funding has contributed to impressive results in the
fight against the three diseases.
In round figures, 10 million people are now on
antiretroviral AIDS treatment under programs funded by
GF.
In the period 2002-15, 16.6 million have received treatment
for tuberculosis
More than 713 million insecticide-treated bed nets have
been distributed in countries receiving support from GF
Support to GF
is directly in line with the strategy “The
World 2030, Denmark’s strategy for development policy
and humanitarian action”, and its aim to place Denmark at
the forefront of international efforts to promote sexual and
reproductive health and rights, including the fight against
HIV/AIDS.
GF is committed to invest in programs that promote and
protect human rights and gender equality, and reduce
human rights barriers to services and increase programing
for key populations.
GF is one of the biggest multilateral funders of the health-
related SDG 3 including increasing investments in
strengthening health systems
Monitoring Danish priority areas based on GF’s
own
framework and indicators
Undertaking a midterm review of the Danish Organisation
Strategy
0
150 150
0
150 150
2017-2022
06.36.03.16
Gitte Hundahl
Mads Ettrup
300
300
* GF will have its 6
th
replenishment in 2019 where contributions for 2020-2022
will be pledged by donors
SDGs relevant for Programme
No Poverty
No
Hunger
Good Health,
Wellbeing
Quality
Education
Gender
Equality
Clean Water,
Sanitation
Justification for support.
Affordable
Clean
Energy
Decent
Jobs, Econ.
Growth
Industry,
Innovation,
Infrastructure
Reduced
Inequalities
Sustainable
Cities,
Communities
Responsible
Consumption
& Production
Climate
Action
Life below
Water
Life on Land
Peace &
Justice,
strong Inst.
Partnerships
for Goals
Budget
Resource Mobilisation
Total Replenishment pledges 2017-2019 USD 12.9 billion
Total Replenishment pledges 2014-2016 USD 12.0 billion
Investments to date in USD (June 2017)
Component Signed
Committed
HIV/AIDS
How will we ensure results and monitor progress
Disbursed
17,508,380,843
5,464,103,001
9,591,972,498
836,577,995
666,850,844
34,067,885,180
Tuberculosis
Malaria
TB/HIV
Other
Total
19,471,402,496
6,254,223,778
11,101,506,323
1,530,696,491
852,147,273
39,209,976,362
18,465,952,235
5,858,858,913
10,392,116,797
1,141,556,105
741,030,890
36,599,514,940
Risk and challenges
Maintaining the high level of funding in a changing funding
landscape and declining availability of ODA
Programmatic impact and systems strengthening, ensuring
that GF invest in the most effective interventions
Misuse of funds and maturity of risk systems
Strat.
objective(s)
Priority Results
Promote and Protect Human
Rights and Gender Equality
Investing to end
Epidemics of
HIV/AIDS,
Tuberculosis and
Malaris
Danish involvement in governance structure
Denmark is part of the Point Seven Constituency in the
GF Board
Point Seven comprise six countries (Denmark, Ireland,
Luxembourg, Netherlands, Norway, and Sweden) and the
Board seat has a two-year rotation among countries
Core information
2001
Geneva
Mark Dybul
50% for HIV, 32% for malaria and 18% for
TB
550 staff
Around 150 countries
Alternate: 2013-2015
Board member: 2015-2017
Established
HQ
Executive director
Division of funding for the 3
diseases
Human Resources
Country presence
Denmark member of
Executive Board
Build Resilient and Sustainable
Systems for Health
Continued institutional
Reform and Risk Management